A Self-controlled Study of Bleomycin and Pingyangmycin Injection in the Treatment of Plantar Warts

All patients were treated as self-control. Half of the warts received bleomycin injection and the other half received pingyangmycin injection for 24 weeks. During the treatment period, before each injection, photos of the skin lesions must be taken, the diameter of the skin lesions must be measured, the DLQI(Dermatology Life Quality Index) and NRS scores(NRS scores) must be filled in, and adverse events must be recorded. Before the first treatment, HPV(Human Papilloma virus) virus typing is performed on the warts.

NCT Number	NCT07197541
Lead Sponsor	Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions	Plantar Wart
Enrollment	200 participants
Start Date	2025-10-01
Primary Completion	2026-11-01 (estimated)
Study Completion	2026-11-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-02